See at
https://youtu.be/ND6suElbZw4Description
News release announcing that researchers at the University of Maryland School of Medicine (UMSOM) have begun testing an experimental stem cell therapy developed by Mesoblast Limited to treat hospitalized COVID-19 patients with moderate to severe acute respiratory distress syndrome (ARDS) who are on ventilators to help them breathe. Additional information available via the accompanying video.Keyword
Coronavirus Disease 2019 (COVID-19)Mesoblast Limited
remestemcel-L
University of Maryland, Baltimore
University of Maryland Medical Center
COVID-19 (Disease)
Stem Cell Research
COVID-19